Ledger.Open graph →
SEC Form D · filed September 5, 2025

Angiocrine Bioscience, Inc

Offering
$3.0M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Paul W. Finnegan · San Diego, CAExec · DirectorDavid L. Parkinson · San Diego, CADirectorJeffrey L. Port · NEW YORK, NYDirectorJohn T. Lomoro · San Diego, CAExecJohn R. Jaskowiak · San Diego, CAExecDavid L. Parkinson · San Diego, CADirectorJeffrey L. Port · San Diego, CADirectorJohn T. Lomoro · San Diego, CAExecPaul W. Finnegan · San Diego, CAExec · DirectorJohn R. Jaskowiak · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗